Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dar Aldawa Dv/Iv | Amman | Healthcare | Pharmaceuticals | JOD 42.35M | 12.1x | 0.85 | JOD 1.21 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Consulting Group | Amman | Healthcare | Healthcare Providers & Services | JOD 35M | 25x | 0.38 | JOD 1.75 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hayat Phat | Amman | Healthcare | Pharmaceuticals | JOD 25.75M | 8.2x | 0.26 | JOD 2.70 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Ibn Alhaytham H. | Amman | Healthcare | Healthcare Providers & Services | JOD 13M | 243.3x | 2.38 | JOD 0.65 | -4.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Philadelphia Pharma Industry | Amman | Healthcare | Pharmaceuticals | JOD 10.28M | 12.4x | 7 | JOD 1.37 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |